This year has, so far, been something of a Jekyll and Hyde market for equities.
Stocks making the biggest moves after the bell: Novavax, First Solar, Rivian and more
These are the stocks posting the largest moves in after-hour trading.
The best fixed income deals for investors as interest rates surge higher
The 10-year Treasury touched a high not seen since Nov. 10. Here are other ways to find income.
Rocket Lab quarterly revenue stays steady as space company doubles order backlog
Rocket Lab said Tuesday it has doubled its order backlog — from about $241 million in contracts at the end of 2021 to $503.6 million at the end of 2022.
Rivian posts mixed fourth quarter and underwhelming EV production outlook, stock falls
The results follow slower-than-expected production, unexpected pricing pressure and plans to lay off 6% of its workforce in a bid to conserve cash.
Novavax shares plunge as company raises doubts about its ability to remain in business
Covid-19 vaccine maker Novavax on Tuesday raised doubts about its ability to remain in business and announced plans to slash spending.
Norwegian Cruise Line shares fall 10% as soft outlook, wider losses eclipse strong demand
Norwegian Cruise Line’s stock fell as high costs and debt weigh on the company even as travel demand has stayed strong.
FDA advisors recommend first-ever RSV vaccine from Pfizer, despite possible Guillain-Barre risks
Several FDA advisors said there could be a significant safety issue after two vaccine recipients out of about 20,000 developed Guillain-Barre syndrome.
Virgin Galactic completes lengthy upgrade process ahead of resuming spaceflights
Virgin Galactic reported fourth-quarter results on Tuesday, with the company saying it remains on track to resume spaceflights in the coming months.
Bitcoin, ether on track for a positive February despite mid-month drop and fading 2023 risk rally
Bitcoin and ether are on pace for a modest February win, even after suffering a big drop earlier in the month.